MARKET

CVM

CVM

CEL-SCI Corp
AMEX
1.190
-0.220
-15.60%
Pre Market: 1.100 -0.09 -7.56% 07:26 05/13 EDT
OPEN
1.040
PREV CLOSE
1.410
HIGH
1.190
LOW
0.8900
VOLUME
435
TURNOVER
--
52 WEEK HIGH
13.48
52 WEEK LOW
0.8900
MARKET CAP
10.06M
P/E (TTM)
-0.2271
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 18h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 23h ago
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
CEL-SCI prices $7.2M offering at $1.20 per share
Seeking Alpha · 1d ago
CEL-SCI 6M share Secondary priced at $1.20
TipRanks · 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 1d ago
CEL-SCI enters strategic agreement with Amarox over Multikine distribution
TipRanks · 1d ago
CEL-SCI Signs Strategic Partnership, Distribution, And Revenue Sharing Agreement With Amarox For Regulatory Affairs, Marketing And Potential Commercialization Of Multikine In Treatment Of Head And Neck Cancer In Saudi Arabia
Benzinga · 1d ago
More
About CVM
CEL-SCI Corporation is a late clinical-stage biotechnology company. It is engaged in research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system. It is focused on the development of product candidates and technologies, including Multikine and Ligand Epitope Antigen Presentation System technology (LEAPS). Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, which is designed to help the immune system target the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. LEAPS is designed to stimulate the human immune system to more effectively fight bacterial, viral and parasitic infections as well as autoimmune conditions, allergies, transplantation rejection and cancer, when it cannot do so on its own. The LEAPS candidates include CEL-2000, CEL-4000 and DerG-PG275(Cit) (aka, CEL-5000).

Webull offers CEL-SCI Corp stock information, including AMEX: CVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CVM stock methods without spending real money on the virtual paper trading platform.